journal article Open Access Jul 28, 2016

Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration

View at Publisher Save 10.1093/cid/ciw506
Abstract
Abstract
Background.  Mass drug administration (MDA) with praziquantel is the cornerstone of schistosomiasis control in sub-Saharan Africa. The effectiveness of this strategy is dependent on the continued high efficacy of praziquantel; however, drug efficacy is rarely monitored using appropriate statistical approaches that can detect early signs of wane.
Methods.  We conducted a repeated cross-sectional study, examining children infected with Schistosoma mansoni from 6 schools in Uganda that had previously received between 1 and 9 rounds of MDA with praziquantel. We collected up to 12 S. mansoni egg counts from 414 children aged 6–12 years before and 25–27 days after treatment with praziquantel. We estimated individual patient egg reduction rates (ERRs) using a statistical model to explore the influence of covariates, including the number of prior MDA rounds.
Results.  The average ERR among children within schools that had received 8 or 9 previous rounds of MDA (95% Bayesian credible interval [BCI], 88.23%–93.64%) was statistically significantly lower than the average in schools that had received 5 rounds (95% BCI, 96.13%–99.08%) or 1 round (95% BCI, 95.51%–98.96%) of MDA. We estimate that 5.11%, 4.55%, and 16.42% of children from schools that had received 1, 5, and 8–9 rounds of MDA, respectively, had ERRs below the 90% threshold of optimal praziquantel efficacy set by the World Health Organization.
Conclusions.  The reduced efficacy of praziquantel in schools with a higher exposure to MDA may pose a threat to the effectiveness of schistosomiasis control programs. We call for the efficacy of anthelmintic drugs used in MDA to be closely monitored.
Topics

No keywords indexed for this article. Browse by subject →

References
38
[1]
Human schistosomiasis

Daniel G Colley, Amaya L Bustinduy, W Evan Secor et al.

The Lancet 2014 10.1016/s0140-6736(13)61949-2
[2]
Vennervald "Morbidity in schistosomiasis: an update" Curr Opin Infect Dis (2004) 10.1097/00001432-200410000-00009
[3]
Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa

Marieke J van der Werf, Sake J de Vlas, Simon Brooker et al.

Acta Tropica 2003 10.1016/s0001-706x(03)00029-9
[4]
el Gaddal "The Blue Nile Health Project: a comprehensive approach to the prevention and control of water-associated diseases in irrigated schemes of the Sudan" J Trop Med Hyg (1985)
[5]
Fenwick "Schistosomiasis: challenges for control, treatment and drug resistance" Curr Opin Infect Dis (2006) 10.1097/01.qco.0000247591.13671.6a
[6]
Rollinson "Time to set the agenda for schistosomiasis elimination" Acta Trop (2013) 10.1016/j.actatropica.2012.04.013
[7]
Fenwick "The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002–2008" Parasitology (2009) 10.1017/s0031182009990400
[8]
Fenwick "New initiatives against Africa's worms" Trans R Soc Trop Med Hyg (2006) 10.1016/j.trstmh.2005.03.014
[9]
Clements "Bayesian spatial analysis and disease mapping: tools to enhance planning and implementation of a schistosomiasis control programme in Tanzania" Trop Med Int Health (2006) 10.1111/j.1365-3156.2006.01594.x
[10]
Fleming "Schistosomiasis Control Initiative website"
[11]
French "Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study" PLoS Negl Trop Dis (2010) 10.1371/journal.pntd.0000897
[12]
Kabatereine "Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren" Bull World Health Organ (2007) 10.2471/blt.06.030353
[13]
Ouedraogo "Schistosomiasis in school-age children in Burkina Faso after a decade of preventive chemotherapy" Bull World Health Organ (2016) 10.2471/blt.15.161885
[14]
World Health Organization "Schistosomiasis: progress report 2001–2011, strategic plan 2012–2020" (2013)
[15]
Knopp "From morbidity control to transmission control: time to change tactics against helminths on Unguja Island, Zanzibar" Acta Trop (2013) 10.1016/j.actatropica.2011.04.010
[16]
Assefa "Diagnostic accuracy and cost-Effectiveness of alternative methods for detection of soil-transmitted helminths in a post-treatment setting in western Kenya" PLoS Negl Trop Dis (2014) 10.1371/journal.pntd.0002843
[17]
Lamberton "Sensitivity and specificity of multiple Kato-Katz thick smears and a circulating cathodic antigen test for Schistosoma mansoni diagnosis pre-and post-repeated-praziquantel treatment" (2014)
[18]
World Health Organization "Assessing the efficacy of anthelminthic drugs against schistosomiasis and soil-transmitted helminthiases" . (2013)
[19]
Walker "Models for measuring anthelmintic drug efficacy for parasitologists" Trends Parasitol (2014) 10.1016/j.pt.2014.08.004
[20]
Lahiri "Resampling methods for dependent data" (2013)
[21]
Walker "New approaches to measuring anthelminthic drug efficacy: parasitological responses of childhood schistosome infections to treatment with praziquantel" Parasit Vectors (2016) 10.1186/s13071-016-1312-0
[22]
R Development Core Team "R: a language and environment for statistical computing" (2015)
[23]
Hadfield "MCMC methods for multi-response generalized linear mixed models: the MCMCglmm R package" J Stat Softw (2010) 10.18637/jss.v033.i02
[24]
Kabatereine "Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda" Trans R Soc Trop Med Hyg (2003) 10.1016/s0035-9203(03)80044-5
[25]
Gelman "Bayesian data analysis." (2014)
[26]
Tukahebwa "A very high infection intensity of Schistosoma mansoni in a Ugandan Lake Victoria fishing community is required for association with highly prevalent organ related morbidity" PLoS Negl Trop Dis (2013) 10.1371/journal.pntd.0002268
[27]
Mutapi "Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection" J Infect Dis (1998) 10.1086/517456
[28]
Zwang "Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis—a meta-analysis of comparative and non-comparative clinical trials" PLoS Negl Trop Dis (2014) 10.1371/journal.pntd.0003286
[29]
[30]
Phyo "Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study" Lancet (2012) 10.1016/s0140-6736(12)60484-x
[31]
Morgan "Origin and diversification of the human parasite Schistosoma mansoni" Mol Ecol (2005) 10.1111/j.1365-294x.2005.02709.x
[32]
Wolstenholme "Drug resistance in veterinary helminths" Trends Parasitol (2004) 10.1016/j.pt.2004.07.010
[33]
Norton "Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania" Am J Trop Med Hyg (2010) 10.4269/ajtmh.2010.10-0283
[34]
Bourguinat "Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment" PLoS Negl Trop Dis (2007) 10.1371/journal.pntd.0000072
[35]
The contribution of mass drug administration to global health: past, present and future

Joanne P. Webster, David H. Molyneux, Peter J. Hotez et al.

Philosophical Transactions of the Royal Society B:... 2014 10.1098/rstb.2013.0434
[36]
Aragon "Towards an understanding of the mechanism of action of praziquantel" Mol Biochem Parasitol (2009) 10.1016/j.molbiopara.2008.11.007
[37]
Lamberton "Modelling the effects of mass drug administration on the molecular epidemiology of schistosomes" Adv Parasitol (2015) 10.1016/bs.apar.2014.12.006
[38]
Crellen "Whole genome resequencing of the human parasite Schistosoma mansoni reveals population history and effects of selection" Sci Rep (2016) 10.1038/srep20954
Metrics
133
Citations
38
References
Details
Published
Jul 28, 2016
Vol/Issue
63(9)
Pages
1151-1159
License
View
Funding
Wellcome Trust
Wellcome Trust Sanger Institute Award: 098051
Schistosomiasis Control Initiative
UNICEF/UNDP/World Bank WHO Special Programme for Research
Training in Tropical Disease
Cite This Article
Thomas Crellen, Martin Walker, Poppy H. L. Lamberton, et al. (2016). Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration. Clinical Infectious Diseases, 63(9), 1151-1159. https://doi.org/10.1093/cid/ciw506